D R Averett

3.4k citations

56 papers · 2.8k indexed · h-index 30

Impact in

Hepatology top 0.5%
- Hepatitis C virus research
Virology top 2%
- HIV Research and Treatment

Papers in

Virology 6
- HIV Research and Treatment 6
Hepatology 10
- Hepatitis C virus research 10

Co-authors: Jeffry Saputelli William S. Mason Carol E. Aldrich Ronna E. Dornsife Lynn D. Condreay Robert C. Tam Thomas A. Krenitsky T Spector
Journals: Antimicrobial Agents and Chemotherapy (13 papers)Journal of Virology (5 papers)Journal of Medicinal Chemistry (4 papers)Journal of Hepatology (3 papers)Journal of Biological Chemistry (3 papers)
Partner nations: United States United Kingdom China

In The Last Decade

D R Averett

55 papers receiving 2.7k citations

Peers

Countries citing papers authored by D R Averett

Since Specialization

Citations

This map shows the geographic impact of D R Averett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D R Averett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D R Averett more than expected).

Fields of papers citing papers by D R Averett

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by D R Averett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D R Averett. The network helps show where D R Averett may publish in the future.

Co-authorship network

The 25 scholars most cited alongside D R Averett, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with D R Averett Line = papers co-authored together D R Averett links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Photocatalysis: Effect of Light-Activated Nanoscale Formulations of TiO₂ on Xanthomonas perforans and Control of Bacterial Spot of Tomato Phytopathology ·Mathews L. Paret, Gary E. Vallad, D R Averett, Jeffrey B. Jones, Stephen M. Olson	2012	115
2	The active metabolite of the TLR7 agonist prodrug ANA773 activates anti-tumor activity by natural killer cells Cancer Research ·Joyce T. Tan, J Marmasse, Simon P. Fletcher, Yasuhide Uegata, Л. М. Колобова, Mitsuharu Ohyama, Ming Yi Guo, D R Averett, James R. Appleman	2007	1
3	Discovery of ANA975: An Oral Prodrug of the TLR-7 Agonist Isatoribine Nucleosides Nucleotides & Nucleic Acids ·Alan X. Xiang, Stephen E. Webber, Bradley M. Kerr, Shui Qing Chen, Joan Carles Trujillo Reyes, N. Beck, Tingmin Wang, Tadeu Chiarelli, Mark R. Herbert, David L. Clark, S. R. STEARMAN, Wěi Li, Simon P. Fletcher, Kevin Steffy, Darian M. Bartkowski, Leonid Kirkovsky, Lisa Bauman, D R Averett	2007	31
4	Masked oral prodrugs of toll-like receptor 7 agonists: a new approach for the treatment of infectious disease. PubMed ·Simon P. Fletcher, Kevin Steffy, D R Averett	2006	33
5	Isatoribine, an Agonist of TLR7, Reduces Plasma Virus Concentration in Chronic Hepatitis C Infection * Hepatology ·Yves Horsmans, Thomas Berg, Jean‐Pierre Desager, Tobias Mueller, Eckart Schott, Simon P. Fletcher, Kevin Steffy, Lisa Bauman, Bradley M. Kerr, D R Averett	2005	195
6	Isatoribine, a toll-like receptor 7 agonist, significantly reduced plasma viral load in a clinical proof-of-concept study in patients with chronic hepatitis C virus infection. Hepatology ·Yves Horsmans, Thomas Berg, Jean‐Pierre Desager, Tobias Müller, E. Schott, Lisa Bauman, Kevin Steffy, Sophie Fletcher, M. E. Bragin, Wen‐Jinn Liaw, B. Kerr, D R Averett	2004	5
7	Validation of Cdc68p as a novel antifungal target Archives of Microbiology ·Ed T. Buurman, Self Pc, Melissa K. McCoy, D R Averett, Craig M. Thompson, Richard Wobbe	2002	5
8	Regulation of both gene expression and protein stability provides genetically assisted target evaluation (GATE) for microbial target validation Pharmacogenomics ·Ed T. Buurman, John Bradley, S. G. Smith, Henar Vallina-Crespo, Judith M. Healy, D R Averett, Craig M. Thompson, C R Wobbe	2001	3
9	A New Synthetic Methodology for Tiazofurin The Journal of Organic Chemistry ·Kanda S. Ramasamy, K Eichler, D R Averett	2000	34
10	Ribavirin polarizes human T cell responses towards a Type 1 cytokine profile Journal of Hepatology ·Robert C. Tam, Bharati Pai, 안원근, Charmaine Lim, D R Averett, Uyen Phan, Tatjana Milovanović	1999	249
11	Lamivudine Therapy of WHV-Infected Woodchucks Virology ·William S. Mason, John M. Cullen, Gloria Moraleda, Jeffry Saputelli, Carol E. Aldrich, Darren S. Miller, Bud C. Tennant, Lloyd Frick, D R Averett, Lynn D. Condreay, Allison R. Jilbert	1998	132
12	A Steady-state and Pre-steady-state Kinetic Analysis of the NTPase Activity Associated with the Hepatitis C Virus NS3 Helicase Domain Journal of Biological Chemistry ·Frank Preugschat, D R Averett, Berwyn Clarke, David Porter	1996	122
13	[[(Guaninylalkyl)phosphinico]methyl]phosphonic Acids. Multisubstrate Analog Inhibitors of Human Erythrocyte Purine Nucleoside Phosphorylase Journal of Medicinal Chemistry ·James L. Kelley, Ed W. McLean, Ronald C. Crouch, D R Averett, Joel V. Tuttle	1995	30
14	In vitro potency of inhibition by antiviral drugs of hematopoietic progenitor colony formation correlates with exposure at hemotoxic levels in HIV positive humans Antiviral Research ·Ronna E. Dornsife, D R Averett	1995	0
15	An Enantiospecific Synthesis of the Human Cytomegalovirus Antiviral Agent [(R)-3-((2-Amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-4- hydroxybutyl]phosphonic Acid Journal of Medicinal Chemistry ·Stanley D. Chamberlain, Karen K. Biron, Ronna E. Dornsife, D R Averett, Lilia M. Beauchamp, George W. Koszalka	1994	21
16	Influence of stereochemistry on antiviral activities and resistance profiles of dideoxycytidine nucleosides Antimicrobial Agents and Chemotherapy ·Mariela del Socorro Prado Olivares, Margaret Tisdale, N. R. Parry, Hui-Gang Wei, Ronna E. Dornsife, Joel V. Tuttle, D R Averett, George W. Koszalka	1994	49
17	High-capacity in vitro assessment of anti-hepatitis B virus compound selectivity by a virion-specific polymerase chain reaction assay Antimicrobial Agents and Chemotherapy ·Robert W. Jansen, Lance C. Johnson, D R Averett	1993	39
18	Anti-HIV compound assessment by two novel high capacity assays Journal of Virological Methods ·D R Averett	1989	33
19	Ribonucleotide reductase induced by varicella zoster virus Biochemical Pharmacology ·Thomas Spector, Jacqueline Stonehuerner, Karen K. Biron, D R Averett	1987	24
20	Ribonucleotide reductase of herpes simplex virus type 2 resembles that of herpes simplex virus type 1 Journal of Virology ·D R Averett, P A Furman, T Spector	1984	16

About D R Averett

D R Averett is a scholar working on Virology, Hepatology, Infectious Diseases, Epidemiology and Immunology, having authored 56 papers that have together received 2.8k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (15 papers), Biochemical and Molecular Research (13 papers), Hepatitis B Virus Studies (10 papers), Hepatitis C virus research (10 papers), Herpesvirus Infections and Treatments (9 papers), Cytomegalovirus and herpesvirus research (8 papers), HIV Research and Treatment (6 papers) and Virus-based gene therapy research (4 papers). The work is most often cited by research in Hepatology (1.0k citations), Virology (420 citations), Infectious Diseases (888 citations), Epidemiology (1.5k citations) and Immunology (388 citations). D R Averett has collaborated with scholars based in United States, United Kingdom and China. Frequent co-authors include Jeffry Saputelli, William S. Mason, Carol E. Aldrich, Ronna E. Dornsife, Lynn D. Condreay, Robert C. Tam, Thomas A. Krenitsky, T Spector, Gloria Moraleda and M H St Clair. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, Journal of Virology, Journal of Medicinal Chemistry, Journal of Hepatology and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact